Roche’s Hemlibra Battles Fierce Competition Amid Rating Hold by Mark Eisenberg 17.06.2024 Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
Deutsche Bank Boosts Oracle Shares, Highlights Growth Potential by Lilu Anderson 17.06.2024 Deutsche Bank's 3% DCF growth rate signals GDP alignment; Analyst warns Oracle's rating, target price risks. AI-assisted, editor-reviewed. Learn more ...
Alignment Healthcare, Inc.: Financial Report Reveals Industry Challenges by Mark Eisenberg 18.04.2024 Alignment Healthcare, Inc. (ALHC) is a Medicare advantage company with revenue growth of 28.6%. Stock price at $5.02, analysts recommend ...
Investing in Philip Morris International: A Smoking-Hot Buy by Terry Bingman 31.03.2024 Global tobacco giant, Philip Morris International, has struggled in recent years but holds potential for growth with its IQOS and ...
Citi Affirms Buy Rating on Pinduoduo with $185 Target by Mark Eisenberg 29.03.2024 Citi maintains its Buy rating on Pinduoduo Inc. with a price target of $185.00. The low PEG ratio suggests potential ...
Telos Boosts Stake in Microsoft Amid Insider Sales – Surprising Details! by Mark Eisenberg 17.02.2024 Telos Capital Management increases its position in Microsoft, while insider transactions and analyst ratings impact the stock. Microsoft's strong financial ...